Healthcare


 Can Pfizer (NYSE:PFE) Advance Its Next-Generation Oncology Pipeline?

Can Pfizer (NYSE:PFE) Advance Its Next-Generation Oncology Pipeline?

July 02, 2026 04:17 AM AEST| By Anmol Khazanchi

Cancer research updates keep a major pharmaceutical name in focus as oncology development, clinical progress, and healthcare innovation shape sector attention and business positioning.

 Why Is Eli Lilly (NYSE:LLY) Obesity Pill In Focus?

Why Is Eli Lilly (NYSE:LLY) Obesity Pill In Focus?

July 02, 2026 04:14 AM AEST| By Anmol Khazanchi

Eli Lilly’s oral obesity treatment expansion keeps metabolic care and healthcare access strategy in focus.

 UnitedHealth Group (NYSE:UNH) Faces Medicare Reset

UnitedHealth Group (NYSE:UNH) Faces Medicare Reset

July 02, 2026 04:04 AM AEST| By Anmol Khazanchi

Medicare Advantage changes, reimbursement pressure, and healthcare cost trends are shaping a major managed care company’s strategy as it reassesses coverage markets and operational priorities.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/us/gallery/xlarge/shutterstock_2498467005_07_02_2026_03_36_25_775066.jpg

Decoy Therapeutics (NASDAQ:DCOY) Jumps 6% Today on New Financing

July 01, 2026 10:30 AM PDT| By Nitish Kishor

• DCOY shares rose 6.40% intraday to $7.65.

 Syndax Pharmaceuticals (NASDAQ:SNDX) Draws Fresh Market Attention

Syndax Pharmaceuticals (NASDAQ:SNDX) Draws Fresh Market Attention

July 02, 2026 02:08 AM AEST| By Anmol Khazanchi

Syndax Pharmaceuticals remains in focus as oncology pipeline progress, financial discipline, and market sentiment shape attention around its position in the biotechnology healthcare space.

 Bruker (NASDAQ:BRKR) Sparks Fresh Lab Tech Buzz

Bruker (NASDAQ:BRKR) Sparks Fresh Lab Tech Buzz

July 02, 2026 02:04 AM AEST| By Anmol Khazanchi

Scientific instruments remain in focus as stronger earnings, dividend continuity, and laboratory technology demand shape market attention around advanced research equipment and healthcare innovation.

 Is Nuvation Bio (NYSE:NUVB) Building A Global Cancer Franchise?

Is Nuvation Bio (NYSE:NUVB) Building A Global Cancer Franchise?

July 02, 2026 12:27 AM AEST| By Anmol Khazanchi

Nuvation Bio continues expanding its global oncology strategy through regulatory progress, pipeline development, and international commercialization efforts.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/us/gallery/xlarge/shutterstock_2557673811_07_02_2026_03_37_19_517870.jpg

Evommune (NYSE:EVMN) Slips Today After EVO756 Trial Misses Primary Endpoint

July 01, 2026 10:30 AM PDT| By Nitish Kishor

• EVMN shares fell 1.39% intraday to $13.11 after the company reported Phase 2b trial results for EVO756.

 Guardian Pharmacy (NYSE:GRDN) Joins Russell 2000 Defensive Indices

Guardian Pharmacy (NYSE:GRDN) Joins Russell 2000 Defensive Indices

July 01, 2026 03:56 PM AEST| By Anmol Khazanchi

Guardian Pharmacy Services continues expanding long-term care pharmacy operations while NYSE Composite healthcare presence includes regional pharmacy networks, medication management, clinical consultation, and pharmaceutical services.

 Becton Dickinson (NYSE:BDX) Advances in NYSE Composite After Vizient Deal

Becton Dickinson (NYSE:BDX) Advances in NYSE Composite After Vizient Deal

July 01, 2026 03:29 PM AEST| By Anmol Khazanchi

Becton Dickinson advanced medical technology initiatives, expanded product developments, and maintained a strong healthcare presence within the NYSE Composite Index through diversified global operations.

 Oscar Health (NYSE:OSCR) Slips on Revenue Miss in NYSE Composite

Oscar Health (NYSE:OSCR) Slips on Revenue Miss in NYSE Composite

July 01, 2026 02:04 PM AEST| By Anmol Khazanchi

Explore Oscar Health business operations, quarterly revenue developments, digital healthcare services, ACA marketplace presence, and healthcare sector activity connected with the NYSE Composite today.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/us/gallery/xlarge/shutterstock_1395560648_07_02_2026_03_34_09_957047.jpg

Beta Bionics (NASDAQ:BBNX) Rises 4% Today Despite Securities Investigation

July 01, 2026 10:29 AM PDT| By Nitish Kishor

• BBNX shares rose 4.36% intraday to $16.35.

 Johnson (NYSE:JNJ) Cancer Drug Progress Sparks Fresh Focus

Johnson (NYSE:JNJ) Cancer Drug Progress Sparks Fresh Focus

July 01, 2026 01:41 AM AEST| By Anmol Khazanchi

Oncology progress, a sharper healthcare structure, and MedTech strength are shaping the latest market debate, while litigation exposure and pipeline execution remain important watch points

 Bruker (NASDAQ:BRKR) Clears A Key Market Test

Bruker (NASDAQ:BRKR) Clears A Key Market Test

July 01, 2026 01:26 AM AEST| By Anmol Khazanchi

Bruker’s move above a key average renewed focus on technical momentum, quarterly performance, valuation, and demand across scientific instrument markets.

 OmniAb (NASDAQ:OABI) Cash Burn Looks Manageable

OmniAb (NASDAQ:OABI) Cash Burn Looks Manageable

July 01, 2026 12:43 AM AEST| By Anmol Khazanchi

OmniAb’s cash burn appears manageable as its debt-free balance sheet, improved spending discipline, and platform revenue progress support a measured financial outlook.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/us/gallery/xlarge/biotechnologyMNMN_07_02_2026_03_16_23_807971.jpg

Modular Medical (NASDAQ:MODD) Rises 3% Today on FDA Software Submission

July 01, 2026 10:09 AM PDT| By Nitish Kishor

• MODD shares rose 3.33% intraday to $4.65.

 GSK plc (NYSE:GSK) Strengthens Healthcare Focus With Antibiotic Progress

GSK plc (NYSE:GSK) Strengthens Healthcare Focus With Antibiotic Progress

June 30, 2026 08:43 PM AEST| By Anmol Khazanchi

GSK plc gained attention after regulatory progress for an oral antibiotic strengthened its anti-infective position and reinforced its broader role across pharmaceutical healthcare innovation.

 Pfizer Inc (NYSE:PFE) Reshapes Healthcare Pipeline Through Dealmaking

Pfizer Inc (NYSE:PFE) Reshapes Healthcare Pipeline Through Dealmaking

June 30, 2026 08:38 PM AEST| By Anmol Khazanchi

Pfizer Inc remains in focus as pipeline expansion, metabolic medicine activity, oncology progress and regulatory developments shape its position within the broader pharmaceutical and healthcare sector.

 Eli Lilly And Company (NYSE:LLY) Advances Metabolic Medicine Frontier

Eli Lilly And Company (NYSE:LLY) Advances Metabolic Medicine Frontier

June 30, 2026 08:33 PM AEST| By Anmol Khazanchi

Eli Lilly and Company remains in focus as metabolic medicine advances, oral therapy progress, and healthcare innovation continue shaping attention across the pharmaceutical sector.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/us/gallery/xlarge/shutterstock_1017371722_07_02_2026_03_18_09_321681.jpg

Nuvectis Pharma (NASDAQ:NVCT) Rises 4% Today as $100 Million Offering Closes

July 01, 2026 10:09 AM PDT| By Nitish Kishor

• NVCT shares rose 4.05% intraday to $19.14 on volume nearly four times the daily average.

 UnitedHealth Group (NYSE:UNH) Rides Healthcare Surge

UnitedHealth Group (NYSE:UNH) Rides Healthcare Surge

June 30, 2026 04:41 AM AEST| By Anmol Khazanchi

UnitedHealth Group gains focus as healthcare strength and managed-care demand shape market sentiment.

 Merck (NYSE:MRK) Draws Heat As Healthcare Surges

Merck (NYSE:MRK) Draws Heat As Healthcare Surges

June 30, 2026 04:29 AM AEST| By Anmol Khazanchi

Healthcare strength, defensive demand, and renewed pharma activity are keeping major drugmakers in focus as market attention shifts toward steadier business models.

 How Is Eli Lilly (NYSE:LLY) Positioned As Healthcare Hits Record Highs?

How Is Eli Lilly (NYSE:LLY) Positioned As Healthcare Hits Record Highs?

June 30, 2026 04:25 AM AEST| By Anmol Khazanchi

Healthcare strength has placed major pharma names in focus as defensive demand, sector rotation, and medicine development continue shaping attention across the broader market.

Sponsored
https://kalkineauuknzusca.blob.core.windows.net/kalkineallsubdata/us/gallery/xlarge/Biopharamanmn_07_02_2026_03_15_56_560027.jpg

Mobile-health Network Solutions (NASDAQ:MNDR) Gains 2% Today as Reverse Split Takes Effect

July 01, 2026 10:07 AM PDT| By Nitish Kishor

• MNDR shares rose 2.00% intraday to $3.12 as its reverse stock split took effect.

 Why Is Teladoc Health Stock In Focus (NYSE:TDOC)

Why Is Teladoc Health Stock In Focus (NYSE:TDOC)

June 30, 2026 02:46 AM AEST| By Team Kalkine Media

Teladoc Health attracts attention through virtual healthcare expansion, Russell index developments, technology innovation, and growing demand for digital medical services across healthcare.

 Why Health Insurance Stocks Are Attracting Attention [S&P 500]

Why Health Insurance Stocks Are Attracting Attention [S&P 500]

June 30, 2026 02:45 AM AEST| By Anmol Khazanchi

Oscar Health, CVS Health, UnitedHealth, Cencora, and Alignment Healthcare remained in focus after quarterly earnings highlighted differing financial performance across healthcare companies

Recent Articles






Investing Tips

Previous Next